Compare UNFI & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNFI | AAPG |
|---|---|---|
| Founded | 1976 | 2009 |
| Country | United States | China |
| Employees | 25600 | N/A |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 1996 | N/A |
| Metric | UNFI | AAPG |
|---|---|---|
| Price | $46.95 | $25.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $44.71 | ★ $48.40 |
| AVG Volume (30 Days) | ★ 637.3K | 1.9K |
| Earning Date | 06-09-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.47 | $332.66 |
| Revenue Next Year | $2.18 | N/A |
| P/E Ratio | $195.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.27 | $20.11 |
| 52 Week High | $49.84 | $48.45 |
| Indicator | UNFI | AAPG |
|---|---|---|
| Relative Strength Index (RSI) | 58.02 | 51.41 |
| Support Level | $43.08 | $24.81 |
| Resistance Level | $47.59 | $28.28 |
| Average True Range (ATR) | 1.59 | 0.37 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 55.08 | 25.85 |
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.